Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments Q Tao, ATC Chan Expert reviews in molecular medicine 9 (12), 1-24, 2007 | 402 | 2007 |
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation J Ying, H Li, TJ Seng, C Langford, G Srivastava, SW Tsao, T Putti, ... Oncogene 25 (7), 1070-1080, 2006 | 312 | 2006 |
Nasopharyngeal carcinoma: an evolving paradigm KCW Wong, EP Hui, KW Lo, WKJ Lam, D Johnson, L Li, Q Tao, ... Nature reviews Clinical oncology 18 (11), 679-695, 2021 | 286 | 2021 |
DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and … B Jin, Q Tao, J Peng, HM Soo, W Wu, J Ying, CR Fields, AL Delmas, X Liu, ... Human molecular genetics 17 (5), 690-709, 2008 | 272 | 2008 |
The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors J Ying, G Srivastava, WS Hsieh, Z Gao, P Murray, SK Liao, R Ambinder, ... Clinical cancer research 11 (18), 6442-6449, 2005 | 258 | 2005 |
Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer J Yu, YY Cheng, Q Tao, KF Cheung, CNY Lam, H Geng, LW Tian, ... Gastroenterology 136 (2), 640-651. e1, 2009 | 256 | 2009 |
WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/β-catenin signaling, and is frequently methylated in colorectal cancer J Ying, H Li, J Yu, KM Ng, FF Poon, SCC Wong, ATC Chan, JJY Sung, ... Clinical cancer research 14 (1), 55-61, 2008 | 244 | 2008 |
Epigenetic disruption of the WNT/ß-catenin signaling pathway in human cancers Y Ying, Q Tao Epigenetics 4 (5), 307-312, 2009 | 228 | 2009 |
Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer L Ai, Q Tao, S Zhong, CR Fields, WJ Kim, MW Lee, Y Cui, KD Brown, ... Carcinogenesis 27 (7), 1341-1348, 2006 | 226 | 2006 |
Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue Q Tao, KD Robertson, A Manns, A Hildesheim, RF Ambinder Blood, The Journal of the American Society of Hematology 91 (4), 1373-1381, 1998 | 220 | 1998 |
Characterization of Epstein-Barr virus–infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict … J Yang, Q Tao, IW Flinn, PG Murray, LE Post, H Ma, S Piantadosi, ... Blood, The Journal of the American Society of Hematology 96 (13), 4055-4063, 2000 | 218 | 2000 |
Nasal NK‐and T‐cell lymphomas share the same type of Epstein‐Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease AKS Chiang, Q Tao, G Srivastava, FCS Ho International journal of cancer 68 (3), 285-290, 1996 | 212 | 1996 |
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of … W Yeo, HC Chung, SL Chan, LZ Wang, R Lim, J Picus, M Boyer, FKF Mo, ... Journal of Clinical Oncology 30 (27), 3361-3367, 2012 | 203 | 2012 |
Epstein-Barr virus (EBV) and its associated human cancers–genetics, epigenetics, pathobiology and novel therapeutics Q Tao, LS Young, CB Woodman, PG Murray Front Biosci 11 (2), 2672-713, 2006 | 179 | 2006 |
Epigenetic identification of ubiquitin carboxyl‐terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors J Yu, Q Tao, KF Cheung, H Jin, FF Poon, X Wang, H Li, YY Cheng, ... Hepatology 48 (2), 508-518, 2008 | 177 | 2008 |
The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21. 3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and … GH Qiu, LKS Tan, KS Loh, CY Lim, G Srivastava, ST Tsai, SW Tsao, ... Oncogene 23 (27), 4793-4806, 2004 | 174 | 2004 |
Promoter methylation of the Wnt/β‐catenin signaling antagonist Dkk‐3 is associated with poor survival in gastric cancer J Yu, Q Tao, YY Cheng, KY Lee, SSM Ng, KF Cheung, L Tian, SY Rha, ... Cancer 115 (1), 49-60, 2009 | 173 | 2009 |
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor … TJ Seng, JSW Low, H Li, Y Cui, HK Goh, MLY Wong, G Srivastava, ... Oncogene 26 (6), 934-944, 2007 | 170 | 2007 |
Cellular uptake, evolution, and excretion of silica nanoparticles in human cells Z Chu, Y Huang, Q Tao, Q Li Nanoscale 3 (8), 3291-3299, 2011 | 162 | 2011 |
The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma L Li, Q Tao, H Jin, A Van Hasselt, FF Poon, X Wang, MS Zeng, WH Jia, ... Clinical Cancer Research 16 (11), 2949-2958, 2010 | 160 | 2010 |